Matt Phipps
Stock Analyst at William Blair
(3.80)
# 1,561
Out of 4,634 analysts
594
Total ratings
48.2%
Success rate
4.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matt Phipps
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AUTL Autolus Therapeutics | Reiterated: Buy | n/a | $2.33 | - | 42 | Aug 11, 2026 | |
| GMAB Genmab | Reiterated: Buy | n/a | $30.85 | - | 26 | Aug 11, 2026 | |
| ZURA Zura Bio | Reiterated: Buy | n/a | $5.56 | - | 2 | Aug 11, 2026 | |
| UPB Upstream Bio | Maintained: Buy | n/a | $7.09 | - | 21 | Aug 11, 2026 | |
| TENX Tenax Therapeutics | Downgraded: Hold | n/a | $1.62 | - | 19 | Aug 10, 2026 | |
| JBIO Jade Biosciences | Maintained: Buy | n/a | $22.35 | - | 6 | Aug 10, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | n/a | $2.20 | - | 8 | Aug 7, 2026 | |
| JANX Janux Therapeutics | Maintained: Buy | n/a | $16.52 | - | 19 | Aug 7, 2026 | |
| EVMN Evommune | Maintained: Hold | n/a | $14.21 | - | 17 | Aug 7, 2026 | |
| INSM Insmed | Maintained: Buy | n/a | $132.57 | - | 14 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $22.10 | - | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $19.63 | - | 23 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $27.62 | - | 15 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.4658 | - | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.85 | - | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $414.30 | - | 39 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.61 | - | 9 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $10.64 | - | 11 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $63.61 | - | 60 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $250.09 | - | 12 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $121.07 | - | 48 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $864.74 | - | 13 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.8931 | - | 18 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $215.77 | - | 1 | Jan 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $117 | $55.42 | +110.68% | 1 | Oct 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $108.49 | - | 1 | Sep 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.83 | - | 19 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.23 | - | 8 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $529.65 | n/a | 1 | Jun 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $60.57 | n/a | 1 | Jun 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.18 | n/a | 5 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.44 | n/a | 11 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1.2 | $15.48 | n/a | 1 | Mar 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8169 | n/a | 13 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $154.30 | n/a | 19 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.94 | n/a | 14 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.0001 | n/a | 11 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.7931 | n/a | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $203.89 | n/a | 26 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $75.50 | n/a | 1 | Jun 11, 2021 |
Autolus Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.33
Upside: -
Genmab
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $30.85
Upside: -
Zura Bio
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.56
Upside: -
Upstream Bio
Aug 11, 2026
Maintained: Buy
Price Target: n/a
Current: $7.09
Upside: -
Tenax Therapeutics
Aug 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.62
Upside: -
Jade Biosciences
Aug 10, 2026
Maintained: Buy
Price Target: n/a
Current: $22.35
Upside: -
Compass Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.20
Upside: -
Janux Therapeutics
Aug 7, 2026
Maintained: Buy
Price Target: n/a
Current: $16.52
Upside: -
Evommune
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $14.21
Upside: -
Insmed
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $132.57
Upside: -
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $22.10
Upside: -
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $19.63
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $27.62
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.4658
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.85
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $414.30
Upside: -
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $5.61
Upside: -
Aug 4, 2026
Maintained: Hold
Price Target: n/a
Current: $10.64
Upside: -
Aug 3, 2026
Maintained: Hold
Price Target: n/a
Current: $63.61
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $250.09
Upside: -
Jul 28, 2026
Maintained: Hold
Price Target: n/a
Current: $121.07
Upside: -
Jul 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $864.74
Upside: -
Jun 1, 2026
Maintained: Hold
Price Target: n/a
Current: $0.8931
Upside: -
Jan 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $215.77
Upside: -
Oct 11, 2025
Reiterated: Buy
Price Target: $117
Current: $55.42
Upside: +110.68%
Sep 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $108.49
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $6.83
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $11.23
Upside: -
Jun 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $529.65
Upside: n/a
Jun 7, 2025
Reiterated: Hold
Price Target: n/a
Current: $60.57
Upside: n/a
Apr 25, 2025
Rated: Hold
Price Target: n/a
Current: $1.18
Upside: n/a
Apr 25, 2025
Rated: Hold
Price Target: n/a
Current: $1.44
Upside: n/a
Mar 29, 2025
Initiated Coverage: Buy
Price Target: $1.2
Current: $15.48
Upside: n/a
Dec 29, 2022
Rated: Hold
Price Target: n/a
Current: $0.8169
Upside: n/a
Jan 3, 2022
Maintained: Buy
Price Target: n/a
Current: $154.30
Upside: n/a
Dec 7, 2021
Maintained: Buy
Price Target: n/a
Current: $8.94
Upside: n/a
Dec 7, 2021
Maintained: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Nov 19, 2021
Maintained: Buy
Price Target: n/a
Current: $0.7931
Upside: n/a
Jul 23, 2021
Rated: Buy
Price Target: n/a
Current: $203.89
Upside: n/a
Jun 11, 2021
Maintained: Buy
Price Target: n/a
Current: $75.50
Upside: n/a